Latest AbbVie Inc. Stories
NEW YORK, March 12, 2015 /PRNewswire/ -- AbbVie's recent acquisition of Pharmacyclics for $21 billion strengthens AbbVie's already comprehensive pipeline and increases the company's growth prospects,
- Adds Imbruvica® a first in class BTK inhibitor approved in multiple indications for blood cancers. NORTH CHICAGO, Ill.
NORTH CHICAGO, Ill., Feb. 19, 2015 /PRNewswire/ -- The board of directors of AbbVie Inc.
DUBLIN, Ireland, February 12, 2015 /PRNewswire/ -- Shire (LSE: SHP, NASDAQ: SHPG) announces unaudited results for the year to December 31, 2014.
- Reports Full-Year Adjusted EPS of $3.32, Up 5.7 Percent; GAAP EPS $1.10 NORTH CHICAGO, Ill., Jan.
ReportsnReports.com adds Hepatitis C Global Clinical Trials Review H2 2014 to its store.
NBI-98854 Phase III Program Underway for Tardive Dyskinesia SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc.
- Reports Third-Quarter Adjusted EPS of $0.89, Up 8.5 Percent and Well Above the Previous Guidance Range of $0.77 to $0.79; Reports GAAP EPS of $0.31 NORTH CHICAGO, Ill., Oct.
- Will announce third-quarter 2014 financial results on Oct. 31, 2014 - NORTH CHICAGO, Ill., Oct. 20, 2014 /PRNewswire/ -- The board of directors of AbbVie Inc.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS
- The practice of two or more parties jointly purchasing all or part of a butchered cow and dividing the meat between them.